A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience - Franche Comté, France.
作者信息
Gallais-Serezal Irène, Puzenat Eve, Moreau Joséphine, Dresco Flora, Pelletier Fabien, Nardin Charlée, Aubin François
机构信息
Dpt of Dermatology, University Hospital, Besançon, France, Inserm 1098 RIGHT, University of Franche Comté, Besançon, France.
Dpt of Dermatology, University Hospital, Besançon, France.
出版信息
Eur J Dermatol. 2021 Feb 1;31(1):101-103. doi: 10.1684/ejd.2020.3960.
Abstract
摘要
相似文献
1
A survey of psoriasis patients on biologics during COVID-19: a high-epidemic area experience - Franche Comté, France.
Eur J Dermatol. 2021 Feb 1;31(1):101-103. doi: 10.1684/ejd.2020.3960.
2
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e682-e684. doi: 10.1111/jdv.16771. Epub 2020 Jul 9.
3
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II.
Dermatology. 2021;237(1):13-14. doi: 10.1159/000513575. Epub 2020 Dec 9.
4
COVID, Biologics, and Psoriasis Therapy.
J Am Acad Dermatol. 2020 Dec;83(6):1577-1578. doi: 10.1016/j.jaad.2020.09.005. Epub 2020 Sep 10.
5
Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China.
Eur J Dermatol. 2020 Dec 1;30(6):738-740. doi: 10.1684/ejd.2020.3908.
6
A survey of psoriasis patients on biologics during COVID-19: a single centre experience.
J Dermatolog Treat. 2022 Feb;33(1):596. doi: 10.1080/09546634.2020.1770165. Epub 2020 May 25.
7
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
J Cutan Med Surg. 2020 Nov/Dec;24(6):625-632. doi: 10.1177/1203475420945234. Epub 2020 Aug 6.
8
COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration.
Dermatol Ther. 2020 Jul;33(4):e13508. doi: 10.1111/dth.13508. Epub 2020 May 28.
9
Should biologics for psoriasis be interrupted in the era of COVID-19?
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
10
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic [Formula: see text].
J Cutan Med Surg. 2021 May-Jun;25(3):298-302. doi: 10.1177/1203475421991126. Epub 2021 Jan 27.
引用本文的文献
1
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.
Psoriasis (Auckl). 2024 May 14;14:29-38. doi: 10.2147/PTT.S451666. eCollection 2024.
2
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
本文引用的文献
1
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16.
2
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.
3
A survey of psoriasis patients on biologics during COVID-19: a single centre experience.
J Dermatolog Treat. 2022 Feb;33(1):596. doi: 10.1080/09546634.2020.1770165. Epub 2020 May 25.
4
COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.
J Am Acad Dermatol. 2020 Jul;83(1):292-294. doi: 10.1016/j.jaad.2020.04.165. Epub 2020 May 6.
5
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration.
Dermatol Ther. 2020 Sep;33(5):e13475. doi: 10.1111/dth.13475. Epub 2020 May 19.
6
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.
Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28.
7
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.
Dermatol Ther (Heidelb). 2020 Apr 16;10(3):339-349. doi: 10.1007/s13555-020-00377-9. eCollection 2020 Jun.
8
Should biologics for psoriasis be interrupted in the era of COVID-19?
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
9
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
Zotero 插件